PHARMATYPE Trademark

Trademark Overview

On Monday, November 2, 2015, a trademark application was filed for PHARMATYPE with the United States Patent and Trademark Office. The USPTO has given the PHARMATYPE trademark a serial number of 86806886. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 1, 2024. This trademark is owned by MRB Partners. The PHARMATYPE trademark is filed in the Advertising, Business and Retail Services category with the following description:

Advertising and marketing
pharmatype

General Information

Serial Number86806886
Word MarkPHARMATYPE
Filing DateMonday, November 2, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 1, 2024
Registration Number5266688
Registration DateTuesday, August 15, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2016

Trademark Statements

Pseudo MarkPHARM A TYPE
Goods and ServicesAdvertising and marketing

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 1, 2024
Primary Code035
First Use Anywhere DateMonday, August 1, 2016
First Use In Commerce DateMonday, August 1, 2016

Trademark Owner History

Party NameMRB Partners
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10001
Party NameMRB Partners
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10001
Party NameMRB Partners
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10001

Trademark Events

Event DateEvent Description
Friday, March 1, 2024CANCELLED SEC. 8 (6-YR)
Monday, August 15, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 15, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, July 11, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sunday, July 9, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, June 8, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 8, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 6, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 6, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 6, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 6, 2017NON-FINAL ACTION E-MAILED
Monday, March 6, 2017SU - NON-FINAL ACTION - WRITTEN
Monday, February 6, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 6, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 2, 2017ASSIGNED TO LIE
Wednesday, January 18, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 30, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 30, 2016NON-FINAL ACTION E-MAILED
Friday, September 30, 2016SU - NON-FINAL ACTION - WRITTEN
Sunday, September 25, 2016STATEMENT OF USE PROCESSING COMPLETE
Tuesday, September 6, 2016USE AMENDMENT FILED
Sunday, September 25, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 6, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, June 7, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 12, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 12, 2016PUBLISHED FOR OPPOSITION
Wednesday, March 23, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 29, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 24, 2016ASSIGNED TO EXAMINER
Saturday, November 7, 2015NOTICE OF PSEUDO MARK E-MAILED
Friday, November 6, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 5, 2015NEW APPLICATION ENTERED

Related Keywords

pharmatype marketing advertising